[1] KIM SY. Diagnosis and treatment of hypopituitarism[J]. Endocrinol Metab(Seoul),2015,30(4):443-455.
|
[2] ZHENG X,LI S,ZHANG WH,et al. Metabolic abnormalities in pituitary adenoma patients:A novel therapeutic target and prognostic factor[J]. Diabetes Metab Syndr Obes,2015,8:357-361.
|
[3] MODY A,WHITE D,KANWAL F,et al. Relevance of low testosterone to non-alcoholic fatty liver disease[J]. Cardiovasc Endocrinol,2015,4(3):83-89.
|
[4] CHISHIMA S,KOGISO T,MATSUSHITA N,et al. The Relationship between the growth hormone/insulin-like growth factor system and the histological features of nonalcoholic fatty liver disease[J]. Intern Med,2017,56(5):473-480.
|
[5] TAKAHASHI Y. Essential roles of growth hormone(GH)and insulin-like growth factor-I(IGF-I)in the liver[J]. Endocr J,2012,59(11):955-962.
|
[6] NYUNT A,KOCHAR N,PILZ DT,et al. Adult cirrhosis due to untreated congenital hypopituitarism[J]. J R Soc Med,2005,98(7):316-317.
|
[7] GONZALEZ ROZAS M,HERNANZ ROMAN L,GONZALEZ DG,et al. Panhypopituitarism due to absence of the pituitary stalk:A rare aetiology of liver cirrhosis[J]. Case Rep Endocrinol,2016,2016:9071097.
|